Chill Brands Group PLC (CHBRF)
Chill Brands Group PLC operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in London, GB. The stock last traded at $0.05, up 48.84% on the session, giving a market capitalisation of $24.5M. On trailing twelve-month figures it carries a trailing P/E of -5.61, a net margin of -1080.1%. Its beta of 0.80 implies it has historically moved less than the broad market.
Chill Brands Group PLC, a London-based company founded in 2014, specializes in the comprehensive process of bringing consumer products to market – from initial research and development through to manufacturing and distribution. The firm's offerings primarily consist of cannabidiol (CBD) consumer items and a broader array of lifestyle goods, which are sold under the Chill.com and Zoetic brands. Geographically, its operations span the United States, the United Kingdom, and the wider European continent. The product range includes tobacco alternatives, such as smokes and chewable pouches, as well as various wellness and personal care items like oral tinctures, soft-gel capsules, massage oils, and topical cosmetic solutions. The company formally adopted the name Chill Brands Group PLC in August 2021, having previously been known as Zoetic International Plc.
Chill Brands Group PLC is most often compared with the following Healthcare names: